Welcome to Medis, an established company specializing in high quality generic pharmaceuticals. Founded in 1985, we pride ourselves on building strong and enduring business partnerships.
Medis draws on the development and manufacturing capabilities of its parent company, Actavis, whose R&D specialists maintain a strong development pipeline.
Today, our customer base spans more than 130 countries covering over 200 territories. Our broad portfolio includes well over 220 quality pharmaceuticals.
Medis, as the largest third-party out-licensing business globally, is an exemplary business partner for all pharmaceutical products and intellectual property. We have offices in Australia, France, Germany, Iceland and Spain, as well as local presence in 9 other countries and regions around the world.